Transcript www.bloodjournal.org

Hazard ratios (HR) for major bleeding or major plus clinically relevant nonmajor bleeding (CRNB)
and their 95% confidence intervals (CI) in phase 3 trials comparing NOACs with conventional
therapy for acute VTE treatment.
Calvin H. Yeh et al. Blood 2014;124:1020-1028
©2014 by American Society of Hematology